Roldán COM

Language: Spanish
References: 11
Page: 647-651
PDF size: 136.39 Kb.

ABSTRACT

Trauma is responsible for 5 million annual deaths around the world with hemorrhage being the principal cause of preventable death in these patients. It has been documented that 25% of the trauma victims have coagulopathy at the time of presentation in the emergency department. The factors that are associated to these bleeding disorders induced by trauma are tissue trauma, systemic hypotension, the activation and consumption of clotting coagulation is a test that is based on a small segment of the total coagulation cascade. Due to this and other limitations, it has presently become important to use Thromboelastography (TEG) and rotation tromboelastometry (ROTEM) to evaluate the real time of the coagulation process. The treatment for adequate hemostatic resuscitation that is needed by the patient can result in a dramatic improvement in the morbidity and mortality for this patient group.

REFERENCES

1. Colaboradores del estudio CRASH-2, Shakur H, Roberts I, Bautista R, Caballero J, Coast T, Dewan Y, El- Sayed H, Gogichaishvili T, Gupta S, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusión in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebocontrolled trial. The Lancet. 2010 Jul 3; 376 (9734): 23 – 32.

2. Davenport R. Pathogenesis of acute traumatic coagulopathy. Transfusion. 2013 Jan 53: 23S – 27S.

3. Ganter M, Pittet, J. New insights into acute coagulopathy in trauma patients. Best Practice and Reserach Clinical Anaesthesiology. 2010 Mar 24(1): 15 – 25.

4. Hess J, Brohi K, Dutton R, Hauser C, Holcomb J, Kluger Y, Mackway- Jones K, Parr M, Rizoli S, Yukioka T, Hoyt D, Bouillon B. The coagulopathy of trauma: A review of mechanisms. The Journal of Trauma. 2008 Oct 65(4): 748 – 754.

5. Jiménez J, De la Peña J, Teheran R, Orozco A. Coagulopatía temprana en trauma: ¿Llegan los pacientes coagulopáticos a la sala de cirugía?. Revista Colombiana de Anestesiología. 2010 38(4): 510 – 525.

6. Jiménez J, Perez J, Navarro R, Gómez M, Monsalve J, Peyró R. Reanimación de control de daños en el paciente con trauma grave. Revista Española de Anestesiología y Reanimación. 2011 59(1): 31 – 42.

7. Mata D. Sangrado Masivo: Uso de Tromboelastometría y Tromboelastografía Rotacional. Revista Médica de Costa Rica y Centroamérica. 2013 608: 607-613.

8. Rollins G. (2014). TEG and ROTEM in Trauma – Induced Coagulopathy. American Association for Clinical Chemestry. Recuperado el 08 de Diciembre de 2014 de www.aacc. arg/publications/cln/articles/2014/ july/coagulation.

9. Rossaint R, Boullion B, Cerny V, Coats T, Duranteau J, Fernandéz- Modéjar E, Filipescu D, et al. The STOP the Bleeding Campaing. Critical Care. 2013 Apr 26;17(2): 136.

10. Spahn D, Bouillon B, Cerny V, Coats T, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt B, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vicent J, Rossaint R. Managment of bleeding and coagulopathy following major trauma: an updated European guideline. Critical Care. 2013 Apr 19;17(2): R76.

11. Vincent J, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn D. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective. Critical Care. 2006 10(4): R120.